TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/25 16:42 | 1/3/25 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Snow Jessica | MA | O | See Rema | S.m | -18 | 2.81 | 0 | -6 | -4 | 147 | D | ||||||||||||||
12/17/24 16:11 | 12/13/24 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Snow Jessica | MA | O | See Rema | S | -7 | 3.23 | 0 | -2 | -1 | 153 | D | ||||||||||||||
8/16/24 17:10 | 8/14/24 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Snow Jessica | MA | O | See Rema | S | -34 | 4.32 | 0 | -8 | -5 | 156 | D | ||||||||||||||
7/3/24 16:14 | 7/2/24 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Snow Jessica | MA | O | See Rema | S | 0 | 4.02 | 0 | 0 | 0 | 164 | D | ||||||||||||||
6/5/24 19:16 | 6/3/24 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Snow Jessica | MA | O | See Rema | S | -3 | 4.18 | 0 | -1 | -1 | 56 | D | ||||||||||||||
5/16/24 18:40 | 5/3/24 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Snow Jessica | MA | O | See Rema | S | 0 | 4.91 | 0 | 0 | 0 | 56 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |